Alternative Treatment Options for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia

被引：0
|
作者：
Pasquale, Timothy R. [1 ]
机构：
[1] Carolinas HealthCare Syst, Div Pharm, Charlotte, NC USA
来源：
INFECTIOUS DISEASES IN CLINICAL PRACTICE | 2016年 / 24卷 / 02期
关键词：
D O I：
10.1097/IPC.0000000000000377
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：67 / +
页数：2
相关论文
共 50 条
  • [1] Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus
    Maclayton, Darego O.
    Hall, Ronald G., II
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (02) : 235 - 244
  • [2] Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Thamlikitkul, Visanu
    Tongsai, Sasima
    CHEST, 2012, 142 (01) : 269 - 270
  • [3] Pharmacotherapy for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Segarra-Newnham, Marisel
    Church, Timothy J.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (12) : 1678 - 1687
  • [4] Linezolid for the Treatment of Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
    Wolff, Michel
    Mourvillier, Bruno
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (01) : 160 - 161
  • [5] Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia
    Hall, Ronald G., II
    CHEST, 2007, 132 (03) : 1100 - 1101
  • [6] Predictors of the pathogenicity of methicillin-resistant Staphylococcus aureus nosocomial pneumonia
    Nagaoka, Kentaro
    Yanagihara, Katsunori
    Harada, Yosuke
    Yamada, Koichi
    Migiyama, Yohei
    Morinaga, Yoshitomo
    Izumikawa, Koichi
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Nishimura, Masaharu
    Kohno, Shigeru
    RESPIROLOGY, 2014, 19 (04) : 556 - 562
  • [7] The economic impact of nosocomial methicillin-resistant Staphylococcus aureus pneumonia
    Ott, E.
    Graf, K.
    Schwab, F.
    Reichardt, C.
    Chaberny, I. F.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 27 - 27
  • [8] Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
    Hooper, Candace Y.
    Smith, Winter J.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 131 - 137
  • [9] Risk factors of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Torre-Cisneros, Julian
    Tejero Garcia, Rocio
    Natera Kindelan, Clara
    Font Ugalde, Pilar
    Franco Alvarez de Luna, Francisco
    Caston Osorio, Juan Jose
    Rivero Roman, Antonio
    Casal Roman, Manuel
    MEDICINA CLINICA, 2012, 138 (03): : 99 - 106
  • [10] Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia
    Jung, Young Ju
    Koh, Younsuck
    Hong, Sang-Bum
    Chung, Joo Won
    Choi, Sang Ho
    Kim, Nam Joong
    Kim, Mi-Na
    Choi, Ik Su
    Han, Song Yi
    Kim, Won-Dong
    Yun, Sung-Cheol
    Lim, Chae-Man
    CRITICAL CARE MEDICINE, 2010, 38 (01) : 175 - 180
12345